PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193433
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193433
CRISPR Technology Market size was valued at USD 590.6 Million in 2022, expanding at a CAGR of 28.1% from 2023 to 2030.
CRISPR is a tool for genome editing. Researchers and medical personnel utilize it to change DNA sequences and influence gene function. Additionally, CRISPR is utilized to treat human diseases, correct genetic flaws, and produce better agricultural kinds. It makes it simple for scientists to change DNA sequences and further manipulate gene function.
The market for CRISPR Technology is driven by the rising development in genome editing, and gene discovery. In addition, increasing government and private financing, expanding demand for and use of CRISPR, and technological improvements are some of the specific drivers boosting the market's growth. The government frequently funds the development of CRISPR technology through individual investigator grants, government and private company grants for research initiatives and programs, and other methods that are intended to expand the market. Further, COVID-19 sparked the creation of sophisticated diagnostic kits utilizing CRISPR technology and helped the industry expand during the epidemic.
Additionally, CRISPR technology advances genome editing in the disciplines of health, biotechnology, and agriculture, making it possible for researchers in these sectors to conduct research globally through faster and more effective genome editing. Thus, due to its quick, simple, and affordable access to vectors as well as the consequent next-generation tools, CRISPR technology is in more demand. Numerous diseases can be treated by CRISPR-Cas9, including inherited eye disorders, neurological diseases like Alzheimer's and Huntington's, and non-inherited problems including cancer and HIV. The global CRISPR technology market is expected to expand as interest in gene therapies increases. Due to several variables, including the rise in the prevalence of numerous genetic illnesses like hemophilia, the focus on gene therapies has increased globally.
The Global CRISPR Technology Market is segmented on the basis of Product, Application, End User, and Region.
The market is split into four categories based on Product: enzymes, kits and reagents, guide RNA, and others. The kits & reagents segment dominates the market. Growing demand CRISPR kits and reagents is mainly contributing to segment growth.
The market is segmented into four categories based on application: biomedical, agricultural, industrial, and others. The biomedical segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to a rise in the demand for CRISPR technology in medical diagnostics.
The market is segmented into five categories based on end user: biotechnology & pharmaceutical companies, academics & research institutes, and others. The biotech & pharmaceutical companies segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the demand for CRISPR technology in pharma and biotech development is boosting the segment growth.
The worldwide market for CRISPR technology is highly fragmented in nature which comprised of large and small-sized market players with few large dominating the global market share. The companies in market emphasize on adopting aggressive strategies to reach out large consumer base. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, partnerships, distribution network development, R&D spending, and mergers and acquisitions.
For instance, in September 2022, Mammoth Biosciences raised over USD 195 million of financing at a valuation of the company's CRISPR technology, Cas 14.
Key features of the study:
This proposed research study on CRISPR Technology market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for CRISPR Technology market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the CRISPR Technology market
Impact of COVID-19 on CRISPR Technology market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on CRISPR Technology market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the CRISPR Technology market, we have also included competitive landscape and key innovator analysis for the CRISPR Technology market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the CRISPR Technology market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global CRISPR Technology market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CRISPR TECHNOLOGY MARKET KEY PLAYERS
Thermo Fisher Scientific
Integrated DNA Technology
CSIR-Institute of Genomics & Integrative Biology
Eurofins Genomics India
Setsurotech Co., Ltd.
GLOBAL CRISPR TECHNOLOGY MARKET, BY PRODUCT
Kits and reagents
GLOBAL CRISPR TECHNOLOGY MARKET, BY APPLICATION
GLOBAL CRISPR TECHNOLOGY MARKET, BY END USER
Biotechnology & pharmaceutical companies
Academics & research institutes
GLOBAL CRISPR TECHNOLOGY MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
The Middle East and Africa
United Arab Emirates
Rest of MEA